Skip to main content

Human sperm vitrification: the state of the art

Abstract

Sperm cryopreservation has been widely used in assisted reproductive technology (ART) and has resulted in millions of live births. Two principal approaches have been adopted: conventional (slow) freezing and vitrification. As a traditional technique, slow freezing has been successfully employed and widely used at ART clinics whereas the latter, a process to solidify liquid into an amorphous or glassy state, may become a faster alternative method of sperm cryopreservation with significant benefits in regard to simple equipment and applicability to fertility centers. Sperm vitrification has its own limitations. Firstly, small volume of load is usually plunged to liquid nitrogen to achieve high cooling rate, which makes large volume sample cryopreservation less feasible. Secondly, direct contact with liquid nitrogen increases the potential risk of contamination. Recently, new carriers have been developed to facilitate improved control over the volume and speed, and new strategies have been implemented to minimize the contamination risk. In summary, although sperm vitrification has not yet been applied in routine sperm cryopreservation, its potential as a standard procedure is growing.

Background

Over 8 decades ago, in 1938, Luyet and Hoddap performed the first vitrification of frog sperm in liquid air [1]. Polge et al. [2] at the National Institute for Medical Research in London, England claimed “Revival of spermatozoa” after they successfully froze sperm samples from various species with glycerol [2]. Sperm cryopreservation has been widely used in assisted reproductive technology (ART) programs, including infertility treatment and cancer patient fertility preservation. Its application can be a therapeutic solution for patients with male infertility. The first attempt using vitrified sperm for human live birth was reported in 1953 by two researchers from State University of Iowa, using sperm frozen on dry ice [3], and soon after the publication, normal live birth was declared. About one decade later, the same group tried with liquid nitrogen (LN2) and succeeded [4, 5]. Live births from frozen sperm after 4 decades storage in LN2 had been reported [6]. Cryopreservation of spermatozoa has been the most valuable and used way to preserve the fertility of males, including those undergoing chemotherapy or radiotherapy, those with severe oligospermia or ejaculatory disorder, and those with disorders leading to testicular damage.

Currently, there are two principal methods applied to the cryopreservation of human sperm, namely, conventional freezing and vitrification. Conventional freezing, slow freezing, a traditional technique, has been successfully employed for the cryopreservation of human sperm many times in the past. In contrast, vitrification is a novel technique, and has been a quickly growing alternative method of rapid freezing.

Traditional cryopreservation techniques are still widely used at ART clinics all over the world, but vitrification has become more effective for cryopreserving human spermatozoa after the efforts in past decade [7]. Vitrification, by directly plunging the sperm samples into LN2, is a fast, simple and cost-effective method to cryopreserve human spermatozoa. This method of rapid freezing causes no damage from intracellular ice crystallization during cooling. Live births were achieved with vitrified spermatozoa by intracytoplasmic sperm injection (ICSI) [8] and by intrauterine insemination [9]. A healthy birth using a vitrified sperm sample was recently reported in Spain after a Day 5 blastocyst was monitored and transferred [10].

Cryoinjury, also called cryodamage, is the damage of cryopreserved biological materials due to water phase changes at low temperatures. The mechanisms involve osmotic rupture by extra- or intra-cellular ice formation. Cell viability largely depends on the integrity of plasma membrane as well as the cellular organelles inside [11]. The cooling velocities also affect the physicochemical and biophysical reactions, and thus alter the survival. The emergence of proteomics and transcriptomics may provide some inspiration to understand cryoinjury mechanisms [12,13,14].

Another perspective was raised to elucidate the mechanisms of cryoinjury using a fish spermatozoa model. It is known that mitochondrial membrane potential changes occur during cryopreservation, and these changes reflect the functional normality of cryopreserved spermatozoa. Compared to human spermatozoa, fish spermatozoa have lower mitochondrial membrane cryostability. Therefore, fish spermatozoa can be used as a model to investigate cryostability in human spermatozoa damage [15, 16].

Is vitrification superior to conventional freezing?

Sperm vitrification has been proposed as an alternative after the efforts in past years [7]. Human embryo cryopreservation which has been well established may provide some clues for sperm cryopreservation. Reed et al. [17] reviewed laboratory and clinical data for all frozen embryo replacement cycles from 2012 to 2015 and concluded that vitrification was more effective, as indicated by higher survival in vitrified embryos compared to slow-cooling cryopreservation. Furthermore, vitrification is also reliable and simple to learn and implement in the laboratory while clinical pregnancy and implantation rates outcomes are similar [17], which is supported by other studies have [18,19,20].

One way to address whether vitrification is superior to conventional freezing is to directly compare the two methods using the same semen samples in the same study (Table 1). With 33 human semen samples, an experiment-controlled study found both slow cryopreservation and vitrification had similar results, but the latter was faster, easier and associated with lower toxicity and cost [28]. Le et al. recently carried out a direct comparison between vitrification and slow cryopreservation [32]. They used 105 human fresh semen samples, exclusive of cryptozoospermia and azoospermia, divided them into washed and unwashed halves, and each group was split into two aliquots: one group cryopreserved by conventional freezing while the other by vitrification. It was demonstrated that conventional freezing resulted in higher motility and viability, while spermatozoa undergoing vitrification were healthier regarding morphology and had fewer defects of sperm head, midpiece and tail [32]. Very recently, Pabon et al. [33] used 47 human sperm samples to compare the efficiency of vitrification and conventional freezing protocols. They found vitrification was optimal for sperm cryopreservation as vitrification protocol resulted in better motility recovery and higher mitochondrial activity [33]. Similar results were reported previously by other researchers [22, 24, 25, 27].

Table 1 Comparison of the studies for human spermatozoa conventional freezing and vitrification

A recent study recruited 20 subfertile men with semen characteristics of severe oligoasthenozoospermia to compare the effects of two approaches and found that the vitrification method using only nonpermeable cryoprotectants was an effective alternative to the conventional slow-freeze technique [31]. Using epididymal and testicular spermatozoa, Epis et al. also demonstrated that vitrification resulted in higher mitochondrial membrane potential and motility than conventional freezing [34].

In order to compare the effectiveness of two methods, it is also legitimate to review and summarize the previously published and related articles. Recently, a systematic review and meta-analysis was undertaken to compare these methods [35]. The authors reviewed a total of 2428 published articles and 13 randomized controlled trials including 486 vitrified and 486 conventional cryopreserved sperm samples. They concluded that vitrification was superior to conventional freezing in post-thaw motility, including both total motility and progressive motility, although the efficacy of vitrification varied by vitrification protocol and sample quality [35].

Collectively, human sperm vitrification has shown increasing potential although the procedure needs further optimization as discussed later.

Cryoprotectants and cryodevices in sperm vitrification

Different from embryo vitrification, sperm vitrification with highly concentrated, permeable cryoprotectants is not suitable for spermatozoa because mammalian spermatozoa exposed to hypertonic conditions during cryopreservation results in osmotic shock, and causes the sperm tail to coil at the distal end [36]. Most commonly used permeable cryoprotectants include dimethyl sulfoxide, glycerol, glycol, ethylene and methanol, while albumins, dextrans and egg yolk citrate are often used as nonpermeable cryoprotectants. It is known that controlling the osmolarity during cryopreservation is of great importance. Using permeable cryoprotectants in the cryopreservation media increases the osmolarity, which fluctuates between 600 to 1000 mOsm/L. In contrast, sperm vitrification media is isosmolar between 300 to 396 mOsm/L, which can be achieved with the use of nonpermeable cryoprotectants or a combination. Vitrification of spermatozoa, free of permeable cryoprotectants, is important to maintain sperm fertilization potential such as capacitation, acrosome reaction, and the integrity of cytoplasmic and mitochondrial membranes. Indeed, unlike the results noted above, using permeable cryoprotectants in sperm vitrification resulted in compromised or even lower motility than conventional freezing with permeable cryoprotectants [21,22,23, 29] (Table 1). Isachenko et al. [18, 19] used 52 human swim up-prepared ejaculates for vitrification without permeable cryoprotectant. They found that in contrast to conventional freezing with glycerol, vitrified sperm displayed higher motility and integrity rates of cytoplasmic and acrosomal membranes, while no difference in spontaneous cryo-capacitation or acrosome reaction was observed [18].

Slabbert et al. [20] used 35 human semen samples for permeable cryoprotectant-free vitrification. They found that the cryoprotectant-free technology generated higher mitochondrial membrane potential but lower DNA fragmentation with no difference in post-thaw motility compared to conventional slow freezing [20].

Aizpurua et al. [30] used 18 normozoospermic sperm samples to test a permeable cryoprotectant-free vitrification protocol. They found that it generated better recovery rates of good quality sperm and better maintenance of sperm quality than traditional slow-freezing [30]. In addition, they also demonstrated that permeable cryoprotectant-free vitrification presented a higher percentage of live spermatozoa, better preservation of acrosomes, and lower DNA fragmentation. Furthermore, using α-tubulin immunocytochemistry to show sperm cytoskeleton, they found that vitrified sperm had similar labeling patterns in the tail to fresh sperm, but different from slow freezing [30]. However, Agha-Rahimi et al. [26] vitrified 30 human normospermic samples with and without cryoprotectant, and they found that sperm frozen in permeable cryoprotectant did not show any toxicity or any difference in post-thaw motility, DNA fragmentation, or hyaluronan-binding potential [26].

In terms of nonpermeable cryoprotectants, some might perform better than others at specific concentrations. For instance, Schulz et al. compared two different nonpermeable cryoprotectants in vitrification with healthy volunteer semen samples and found post-warming sperm motility using 0.1 mol/L trehalose (69%) was higher than that of widely used 0.25 mol/L sucrose (58%). Furthermore, similar results were obtained at 6 and 12 h post-thaw. 0.1 mol/L trehalose preserved sperm had improved membrane integrity at 0 h post thaw, although no significant improvements at 6 h or 12 h compared to sucrose [37]. Another study found butylhydroxytoluene (BHT), a synthetic analogue of vitamin E, effectively maintained vitrified sperm function at 1 mmol/L, including higher progressive sperm motility after warming, DNA integrity, and lower reactive oxygen species [38]. Further research is needed to investigate the optimal nonpermeable cryoprotectants, their concentrations, or combinations depending on different human semen parameters or on clinical purposes.

Besides open systems like cryoloop, a number of closed carriers have been developed and applied in vitrification, including straw-in-straw, high security vitrification straw, Cryotip, VitriSafe, Cryopette, cryoLogic, Rapid-i, S3 system, and the S3 μS-VTF device [39,40,41,42], many of which have proven effective for different purposes. More carriers are expected to be developed and optimized to facilitate sperm vitrification in the future. With the rapid progress of 3-D printing technology, it is now possible to design and print a freezing device. This technique could become a flexible, inexpensive and standard approach to produce freezing devices [43]. One of the 3-D printing thermoplastics, polylactic acid, has proved to be well suited to use for cryogenic activities and is routinely used in 3-D printers already. Because engineering grade 3-D printing can be easily standardized and modified, 3-D printing to form a freezing device has shown its potential applications in sperm cryopreservation.

Does vitrification have to be ultra-fast freezing?

It is believed that, to avoid cryo-damage in vitrification, the loading volume of samples in each carrier must be low enough to achieve high cooling rates [44, 45]. Reducing volume also helps reduce the chance of ice nucleation. By direct plunging into LN2, sperm samples can reach cooling rates of 2, 000–10, 000 °C/min. However, reducing sample volumes limits efficiency in practice, since too many frozen units with small volumes (≤20 μl) not only make the operation process time-consuming, but also make it hard to collect enough number of motile sperm after warming.

[30] compared the efficiency of slow and ultra-rapid freezing and determined the level of DNA fragmentation after slow freezing-thawing and vitrification-warming. With 18 normal human semen samples, they found that ultra-rapid freezing resulted in higher progressive motility (18% vs 11%), higher mormal morphology rate, vitality, and lower sperm DNA fragmentation (20% vs 27%) compared to slow freezing. They concluded that the sperm ultra-rapid freezing was superior to slow freezing [30]. More recently, Hosseini et al. [46] prepared human samples from normozoospermic ejaculates by swim-up, and low number of human spermatozoa were frozen by directly submerging in LN2 or its vapor. They found that direct submerging generated higher sperm progressive motility and total motility rates, lower alterations in sperm chromatin indicated by chromomycin-A3 and Aniline Blue staining, but did not affect morphology, acrosome integrity or DNA damage [46].

Using different size of straws for vitrification, a research group vitrified 22 fertile human donor semen samples with few spermatozoa. They used a micro-straw (50–100 μl) as well as traditional straws (0.25 ml and 0.5 ml). Compared to sperm samples frozen in traditional straws, the sperm frozen in micro-straws showed higher sperm motility after freezing-thawing with no difference in morphology, acrosome, or DNA integrity [47]. The authors thought as the micro-straws were thinner and they hold very small volume, the freezing rate was much faster. To freeze a very small number of human spermatozoa, a multi-well mini plate has been newly developed for vitrification using ~ 1 μl droplets. Sperm frozen using this method showed descent recovery rates and post thaw motility [48]. This novel approach was commented by Paffoni and Palini [49] [49].

As noted above, some scientists suggested using fish spermatozoa freezing model to investigate the mechanisms of why cryoprotectant-free vitrification for human ejaculates is better than conventional freezing and vitrification with cryoprotectants [15, 16, 50].

In contrast, Isachenko et al. [51] found the cooling speed didn’t have to be ultra-fast. They compared the quality of human sperm vitrification method (720, 000 °C/min) and relative slow cooling using LN2 vapor (150–250 °C/min) without any cryoprotectant agents by cryoloop. They found both cooling modes led to comparable results in terms of the motility, fertilization ability, and DNA integrity of the warmed spermatozoa [51]. It appears that a wide range of cooling rates are applicable. If the cooling speed during vitrification is flexible, aseptic vitrification with double straw containing higher volumes of 0.1 to 0.5 mL would allow the use of these techniques in human ART [18, 19]. Interestingly, in human embryo vitrification, embryo survival is higher for large-volume vitrification, which has lower cooling rate comapred to micro-volume vitrification [17].

Vitrified specimen warming

Besides the high-speed freezing (2, 000 °C/mL), the warming velocity should also be high so that the water inside spermatozoa passes from glassy state to liquid without ice crystal formation. Using human spermatozoa samples, Sanchez et al. [52] found the temperatures in the devitrification process were essential for preserved morphological membrane integrity and sperm function [52]. Furthermore, Mansilla et al. [53] tried to determine the optimal warming temperature after human spermatozoa vitrification and found the progressive motility in sperm samples warmed at 42 °C (65%) was higher than those at 38 °C (26%) and 40 °C (57%) and plasma membrane function was also better preserved at 42 °C [53]. Ali Mohamed [28] also warmed vitrified human sperm samples in prewarmed medium at 42 °C [28]. Pabon et al. warmed vitrified human spermatozoa micropills (5–10 μl each) in 500 μl medium prewarmed and maintained at 44 °C for 5 s and observed descent post-thaw motility and mitochondrial activity [33]. Another report noted above warmed vitrified human sperm samples (30 μl pellets) in a 37 °C water bath for 5 min resulting in motile and fertile sperm [32], indicating the flexibility of warming procedure.

What is the contamination risk using sperm vitrification?

Most of the proposed sperm vitrification methods, such as cryoloop, are described as open systems to obtain high cooling rate [51]. This brings the major disadvantage of potential contamination risk as open systems expose the semen samples directly to LN2.

Nitrogen was first liquefied in 1883 by Polish physicists Wroblewski and Olszewski. The liquid-to-gas expansion ratio of nitrogen is 1:694. Liquid nitrogen is commercially produced by compressing air and using fractional distillation. Unless specifically requested, commercial liquid nitrogen provided by suppliers is not sterile. Therefore, it is a potential source of contamination as a number of infectious agents can survive at cryogenic temperatures. It has been well documented that unsterilized commercial LN2 possibly carries microorganisms which increase the risk of transmission and propagation of diseases. A large variety of bacterial, viral and fungal species has been found in liquid nitrogen [54,55,56,57]. Common bacterial contaminants include Pseudomonas spp., Enterobacter cloacae, Staphylococcus sciuri, Acinetobacter calcoaceticus, and Flavobacterium spp. [54].

Indeed, the survival of cryogenic pathogens in LN2 generates the possibility of cross-contamination between LN2 and stored samples because sterile LN2 can get contaminated from stored contaminated semen samples thus become a source of contamination itself [50, 54, 58]. The ingredients used during cryopreservation, especially the cryoprotectants and media increase the survivability of these pathogens. Furthermore, repeated freezing and warming could affect the survival of pathogens in different ways [59]. Relatively, fungi are sensitive to freezing while bacteria have a high tolerance. Piasecka-Serafin [60] reported translocation of bacteria from infected semen pellets, to sterile LN2, and then to sterile semen pellets. Within only 2 hours of cryostorage, as many as 94% of the sterile samples became contaminated with E. coli and S. aureus [60]. The ability of pathogens to survive in LN2 was further demonstrated in LN2 contaminated with infectious vesicular stomatitis virus [61] and then cross contamination with hepatitis B from cryostored bone marrow due to a packaging leak. This leak affected 4 patients receiving cryostored bone marrow [62].

The ability of cryopreserved materials to become contaminated after storage in contaminated LN2 has been shown in LN2 purposely spiked with different viruses. In this study, bovine embryos were vitrified in either unsealed standard 0.25 ml or modified open pulled straws or in sealed plastic cryovials and then plunged into contaminated liquid phase nitrogen. After 3–5 weeks of storage in the contaminated LN2, the bovine embryos were thawed and sequentially washed. Only those with intact zona pellucida (ZP) were pooled together and tested for bovine viral diarrhea virus (BVDV), bovine herpesvirus-1 (BHV-1), and bovine immunodeficiency virus (BIV). The results showed that all control embryos vitrified in sealed cryovials and straws were free from any viral contamination, but 13 of 61 (21%) batches exposed to BVDV and BHV-1 were positive for viral association while none of 22 batches exposed to BIV in unsealed containers was BIV-positive [54, 56].

Surprisingly, Cobo et al. [63] screened the culture medium and LN2 used to vitrify oocytes and embryos of 24 women for viral RNA and DNA. They found that none of 33 used culture media samples or 27 used LN2 samples was positive with any HIV, hepatitis B virus (HBV) or hepatitis C virus (HCV) contamination, even using an open device for vitrification [63]. A total of 6, 11, and 6 patients were seropositive for HIV, HCV, and HBV, respectively, whereas 1 patient showed a coinfection with HCV and HBV. Seven patients presented positive blood viral load (1 HIV, 1 HBV, 5 HCV). The results of this study may be limited due to the relatively low sample size.

Molina et al. [64] directly compared the contamination risk of bacteria and fungi between open and closed vitrification devices with human oocytes and embryos. Interestingly, they also found that the bacteria cross-contamination risk was no greater for open containers than for closed containers in vitrification and no bacterial or fungal contamination was observed in either open or closed devices storing human oocytes and embryos after 1–2 years storage [64]. To identify the bacteria, suspected samples were inoculated on different agar plates and cultured 2–3 days. If any colonies were presented following innoculation, each was sub-cultured to a new plate for purity. Pure cultures were then Gram stained for morphology and identified. Fungal detection was carried out on Sabouraud dextrose agar with chloranphenicol and the filamentous fungi were identified on the basis of macroscopic and microscopic morphologic features. They found all the five containers used to store oocytes and embryos for 1–17 years were contaminated with bacteria, mainly Bacillus spp, Stenotrophomonas maltophilia and Enterobacter spp., before and after LN2 filling, but none with fungi although the media, device or the LN2 used were free from either bacteria or fungi before use. There were Acinetobacter lwoffii, Alcaligenes faecalis ssp. faecalis, and Sphingomonas paucimobilis at the bottom of storage containers but no fungi were observed. The contamination had no correlation to the number of samples stored or to the time the container had been used. The source of these pathogens could be the cryopreservation environment [64].

Joaquim et al. [58] reviewed the potential hazard of infectious transmission through cryopreserved and banked gametes and embryos in LN2 during cryopreservation including viruses, bacteria and fungi [58]. In recent years, Zika vius has been widespread, and known to cause a serious birth defect known as microcephaly. It is still unknown if Zika virus is able to survive in LN2, but the British Fertility Society had suggested the possibility [65, 66].

Contamination control

No freezing method is absolutely safe. Frequent cleaning of used utensils should be the basic measure, including dry shippers, tanks, dewars, canisters, canes, and sample carriers. However, such maintenance may require samples to be removed from storage, which could put the stored specimen at risk [54,55,56, 58, 67]. Another basic rule to avoid contamination is to store contaminated samples separately in quarantine to minimize the risk of cross contamination if possible. Commercially produced LN2 itself could contain cryogenic pathogens and become the source of contamination. However, obtaining a small amount of sterile LN2 is feasible by sterilizing the air used to create LN2. For instance, McBurnie and Bardo [68] demonstrated that air filtration with 0.22 μm polytetrafluoroethylene efficiently retained Brevundimonas diminuta with extreme temperatures, high pressures, high flow rates, and high concentration of bacteria before LN2 manufacturing. Alternatively, filtration of regular but non-sterile LN2 before the samples are exposed could be even simpler. Indeed, a device called CLAir was developed for use in vitrification of human oocytes and mouse embryos [69]. A 0.22-μm filter equipped inside the canister can produce sterile liquid air at similar temperature to LN2 so that the samples saved in a sealed canister (esther) are only exposed to sterile liquid air. Liquid air showed the same vitrification outcome with human oocytes and mouse embryos but with no contamination while large amounts of contamination with regular LN2 were observed. Presumably, such device could be used to prevent contamination in the sperm vitrification process.

Another basic strategy to control contamination is to avoid direct contact with LN2. It is therefore understandable that closed carriers as used in conventional freezing show lower incidence of contamination in comparison to open ones. Cryoloop, a widely used device in which the specimen is directly submerged into LN2, generates considerable vitrification effects at the expense of severe sample contamination [55]. As using a closed carrier in the vitrification process is not always feasible, evidence has shown that using liquid nitrogen vapor, instead of LN2 itself, to store human sperm samples can lower the risk of viral cross-contamination [70]. Fortunately, efforts to improve the use of closed carriers in sperm vitrification have been made and have shown encouraging results. For example, Isachenko et al. [18, 19] developed an aseptic technology for human spermatozoa vitrification. They used in 0.5 mL insemination straws for immediate intrauterine insemination and achieved satisfactory outcome with normozoospermic and severely oligozoospermic samples [18]. Slabbert et al. [20] used 0.5 ml straws to load 300 μl sample to allow sufficient air space inside the straw to prevent rupturing when immersed into LN2. This method worked successfully with 35 vitrified human semen samples [20]. Diaz-Jimenez et al. [71] cryopreserved six donkey ejaculates, which were vitrified with either 30 μl sperm solution sphere suspensions or 100 μl in 0.25 ml straws with 0.1 M sucrose without glycerol. They found the straw method resulted in higher total and progressive motility while no difference in plasma membrane integrity [71]. It appears that sperm vitrification does not compromise post-thaw motility when using a closed carrier. Straw-in-straw design, or double straw, allows the inner straw contain the specimen and then it is sealed and inserted to outer straw, and then the whole unit is submerged to LN2 so there is no direct exposure to LN2. The design showed considerable vitrification results with 82 mouse D2/D3 embryos in 30 μl solution [72] and 113 human oocytes and 93 blastocysts using 1 μl medium [73]. Still, when loaded, the inner straw containing specimen could explode during freezing and warming due to the air pressure fluctuations. Therefore, a thin, narrow-walled capillary was developed to speed up the temperature conduction and reduce the air volume [74,75,76]. The contamination incidence of this double straw method should be no greater than that of conventional method.

Intermediate methods exist that are a hybrid of open and closed systems to achieve the benefits of each method. Samples can be vitrified by direct contact to a small amount of purified LN2, and are then sealed and stored in large quantities regular LN2. This method has been reported in human embryo vitrification [77], and could be tested for efficacy in sperm vitrification.

Ultraviolet (UV) light could also be a possible solution to reduce the contamination risk to vitrified sperm samples. Treating a small volume of LN2 with UV light at a suitable dose of radiation has been demonstrated to effectively reduce the number of pathogens, including bacteria, viruses, and fungi [78]. It was reported that 8, 000 μW/cm2 of UV light could destroy hepatitis B virus while 330, 000 μW/cm2 destroyed the fungus Aspergillus niger. Most virus become inactivated by UV light at dose of 200, 000 μW/cm2 [79] while Zika virus may have higher resistance to UV light [79]. Therefore, UV light could be a viable solution to reducing contamination rates in non-sterile LN2.

Unfortunately, the application of UV light to LN2 containing human samples is controversial. The UV light used could also cause severe genetic aberrations to stored spermatozoa, and further to fertilized embryos, although a study with human oocytes has demonstrated no adverse effects [80]. A simple solution is to sterilize LN2 with UV light before it is used to freeze and store semen samples. Rinsing contaminated samples with sterile LN2 can significantly reduce the contaminant pathogens. Parmegiani et al. [75] washed human oocytes and embryos purposely contaminated with bacteria (P. aeruginosa, E. coli, and S. maltophilia) and a fungus (A. Niger) three times in LN2 sterilized by UV light. Washing these samples in sterilized LN2 eliminated the contamination of both bacteria (0/65) and the fungus (0/25) while the unwashed samples remained highly contaminated with both bacteria (92/117) and fungi (25/25) [75]. Another concern with the use of UV light to sterilize LN2 is the generation of ozone, which could have detrimental effects on the buffering system in which the cryogenic samples are stored. Luckily, the formation of ozone from UV light is insignificant as ozone is formed by the breakdown of oxygen molecules by the action of UV radiation. When these oxygen atoms separate, they combine with other oxygen molecules to form ozone. However, as LN2 is virtually free from oxygen, this should not be an issue with UV light sterilization of LN2 [80].

Generally, there is no easy but cost-effective way to completely eliminate all the potential risks of contamination in sperm vitrification. But based on the improvements in past years, it is possible to control the contamination risk of vitrification to the level of conventional freezing.

Is there a universal vitrification protocol for all types of sperm samples?

Careful optimization of preservation protocols can be tedious, confusing and expensive due to the specific devices and reagents required. Is it possible to develop a universal protocol for all the species and all the samples? It sounds impossible since the cryotolerance of spermatozoa depends on sperm features such as size, shape, and lipid composition, which makes it challenging to generate a single standardized freezing procedure for all species. Even in humans, there is a variety of sperm specimens, such as normospermic, oligospermic, azoospermic samples, testicular sperm aspiration (TESA), and percutaneous epididymal sperm aspiration (PESA) samples with different parameters such as volume, concentration, motility, and seminal plasma features. Furthermore, it is difficult to establish a universal stereotyped model to serve different cryopreservation purposes at human clinic. Rozati et al. [81] reviewed the pitfalls of human sperm cryopreservation, especially the sperm banking for cancer patients [81].

In fact, there was an effort to establish a universal vitrification method for almost all the samples including oocytes, primary cells, stem cells, and genetically modified cells. The method proposed low concentrations of cryoprotectants including 1.5 M propanediol and 0.5 M trehalose in industrial grade microcapillaries made of highly conductive fused silica. It was demonstrated that this universal protocol achieved high recovery and viability rates after vitrification for human mammary epithelial cells, rat hepatocytes, tumor cells from pleural effusions, and multiple cancer cell lines [82]. Unfortunately, due to the different characteristics of spermatozoa from the cell types tested, this method would not likely be superior to the specialized sperm cryopreservation protocols that exist presently.

Conclusion

In the past decade, clinical application of vitrification was one of the most important achievements in human ART. Currently, conventional sperm freezing is still the primary method used for sperm cryopreservation at ART clinics, but sperm vitrification has shown great advantages. Technically, sperm vitrification has substantial difference from conventional slow freezing and from oocyte and embryo vitrification due to the propensity of sperm to become cryodamaged. More and more studies have shown that a vitrification approach free from any non-permeable cryoprotectants performs better than conventional slow freezing protocol for human sperm cryopreseravtion. Sperm vitrification usually requires a small volume of load to achieve high cooling rate, which makes it less feasible with samples of large volumes, but in the past few years, many new designs of larger volume have been tested and developed, and promising results have been achieved. The potential risk of contamination from using open carriers to obtain ultra-fast freezing speeds has been a concern of sperm vitrification. Recently, more and more strategies have been raised to reduce the contamination risk, including new vitrification carriers/designs to both control the risk and improve cryopreservation efficiency. The advancements of 3-D printing tested in recent years could provide a novel approach for manufacturing freezing devices that minimize contamination risk. In terms of potential contamination risk to a variety of cryogenic pathogens, many possible solutions have been identified to control and reduce contamination risk to acceptable levels. Finally, depending on the variety of semen parameters and on the personalized purposes at ART clinics, specific sperm cryopreservation approaches should be individually designed to reach the optimal results.

Availability of data and materials

N/A

Abbreviations

3-D:

3 dimensional

ART:

Assisted reproductive technology

BHT:

Butylhydroxytoluene

BHV-1:

Bovine herpesvirus-1

BIV:

Bovine immunodeficiency virus

BVDV:

Bovine viral diarrhea virus

HBV:

Hepatitis B virus

HCV:

Hepatitis C virus

HIV:

Human immunodeficiency virus

ICSI:

Intracytoplasmic sperm injection

LN2 :

Liquid nitrogen

PESA:

Percutaneous epididymal sperm aspiration

TESA:

Testicular sperm aspiration

UV:

Ultraviolet

ZP:

Zona pellucida

References

  1. 1.

    Luyet BJ, Hodapp EL. Revival of Frog’s spermatozoa vitrified in liquid air. Exp Biol Med. 1938;39:433–4.

    Article  Google Scholar 

  2. 2.

    Polge C, Smith AU, Parkes AS. Revival of spermatozoa after vitrification and dehydration at low temperatures. Nature. 1949;164:666.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  3. 3.

    Bunge RG, Sherman JK. Fertilizing capacity of frozen human spermatozoa. Nature. 1953;172:767–8.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  4. 4.

    Perloff WH, Steinberger E, Sherman JK. Conception with human spermatozoa frozen by nitrogen vapor technic. Fertil Steril. 1964;15:501–4.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  5. 5.

    Sherman JK. Improved methods of preservation of human spermatozoa by freezing and freeze-drying. Fertil Steril. 1963;14:49–64.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  6. 6.

    Szell AZ, Bierbaum RC, Hazelrigg WB, Chetkowski RJ. Live births from frozen human semen stored for 40 years. J Assist Reprod Genet. 2013;30:743–4.

    PubMed  PubMed Central  Article  Google Scholar 

  7. 7.

    Kuznyetsov V, Moskovtsev SI, Crowe M, Lulat AG, Librach CL. Vitrification of a small number of spermatozoa in normozoospermic and severely oligozoospermic samples. Syst Biol Reprod Med. 2015;61:13–7.

    PubMed  Article  PubMed Central  Google Scholar 

  8. 8.

    Isachenko V, Isachenko E, Petrunkina AM, Sanchez R. Human spermatozoa vitrified in the absence of permeable cryoprotectants: birth of two healthy babies. Reprod Fertil Dev. 2012;24:323–6.

    PubMed  Article  PubMed Central  Google Scholar 

  9. 9.

    Sanchez R, Isachenko V, Petrunkina AM, Risopatron J, Schulz M, Isachenko E. Live birth after intrauterine insemination with spermatozoa from an oligoasthenozoospermic patient vitrified without permeable cryoprotectants. J Androl. 2012;33:559–62 49:1-3.

    PubMed  Article  PubMed Central  Google Scholar 

  10. 10.

    Medrano L, Enciso M, Gomez-Torres MJ, Aizpurua J. First birth of a healthy infant following intra-cytoplasmic sperm injection using a new permeable cryoprotectant-free sperm vitrification protocol. Cryobiology. 2019;87:117–9.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  11. 11.

    Jang TH, Park SC, Yang JH, Kim JY, Seok JH, Park US, Choi CW, Lee SR, Han J. Cryopreservation and its clinical applications. Integrative Med Res. 2017;6:12–8.

    Article  Google Scholar 

  12. 12.

    Hezavehei M, Sharafi M, Kouchesfahani HM, Henkel R, Agarwal A, Esmaeili V, Shahverdi A. Sperm cryopreservation: a review on current molecular cryobiology and advanced approaches. Reprod BioMed Online. 2018;37:327–39.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  13. 13.

    Lv C, Wu G, Hong Q, Quan G. Spermatozoa cryopreservation: state of art and future in small ruminants. Biopreserv Biobank. 2019;17:171–82.

    PubMed  Article  PubMed Central  Google Scholar 

  14. 14.

    Paoli D, Lombardo F, Lenzi A, Gandini L. Sperm cryopreservation: effects on chromatin structure. Adv Exp Med Biol. 2014;791:137–50.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  15. 15.

    Isachenko V, Sanchez R, Rahimi G, Mallmann P, Isachenko E, Merzenich M. Cryoprotectant-free vitrification of spermatozoa: fish as a model of human. Andrologia. 2019;51:e13166.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  16. 16.

    Xin M, Siddique MAM, Dzyuba B, Cuevas-Uribe R, Shaliutina-Kolesova A, Linhart O. Progress and challenges of fish sperm vitrification: a mini review. Theriogenology. 2017;98:16–22.

    PubMed  Article  PubMed Central  Google Scholar 

  17. 17.

    Reed ML, Said AH, Thompson DJ, Caperton CL. Large-volume vitrification of human biopsied and non-biopsied blastocysts: a simple, robust technique for cryopreservation. J Assist Reprod Genet. 2015;32:207–14.

    PubMed  Article  PubMed Central  Google Scholar 

  18. 18.

    Isachenko V, Maettner R, Petrunkina AM, Mallmann P, Rahimi G, Sterzik K, Sanchez R, Risopatron J, Damjanoski I, Isachenko E. Cryoprotectant-free vitrification of human spermatozoa in large (up to 0.5 mL) volume: a novel technology. Clin Lab. 2011a;57:643–50.

    PubMed  CAS  PubMed Central  Google Scholar 

  19. 19.

    Isachenko E, Rahimi G, Mallmann P, Sanchez R, Isachenko V. Novel approaches to the cryopreservation of human spermatozoa: history and development of the spermatozoa Vitrification technology. J Reprod Stem Cell Biotechnol. 2011b;2:128–45.

    Article  Google Scholar 

  20. 20.

    Slabbert M, du Plessis SS, Huyser C. Large volume cryoprotectant-free vitrification: an alternative to conventional cryopreservation for human spermatozoa. Andrologia. 2015;47:594–9.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  21. 21.

    Saritha KR, Bongso A. Comparative evaluation of fresh and washed human sperm cryopreserved in vapor and liquid phases of liquid nitrogen. J Androl. 2001;22:857–62.

    PubMed  CAS  PubMed Central  Google Scholar 

  22. 22.

    Nawroth F, Isachenko V, Dessole S, Rahimi G, Farina M, Vargiu N, Mallmann P, Dattena M, Capobianco G, Peters D, Orth I, Isachenko E. Vitrification of human spermatozoa without cryoprotectants. Cryo Lett. 2002;23:93–102.

    CAS  Google Scholar 

  23. 23.

    Chang HJ, Lee JR, Chae SJ, Jee BC, Suh CS, Kim SH. Comparative study of two cryopreservation methods of human spermatozoa: vitrification versus slow freezing. Fertil Steril. 2008;90:S280.

    Article  Google Scholar 

  24. 24.

    Vutyavanich T, Piromlertamorn W, Nunta S. Rapid freezing versus slow programmable freezing of human spermatozoa. Fertil Steril. 2010;93:1921–8.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  25. 25.

    Moskovtsev SI, Lulat GM, Librach CL. Cryopreservation of human spermatozoa by vitrification vs. slow freezing: Canadian experience. Curr Front Cryobiol. 2012:77–100.

  26. 26.

    Agha-Rahimi A, Khalili MA, Nabi A, Ashourzadeh S. Vitrification is not superior to rapid freezing of normozoospermic spermatozoa: effects on sperm parameters, DNA fragmentation and hyaluronan binding. Reprod BioMed Online. 2014;28:352–8.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  27. 27.

    Zhu J, Jin RT, Wu LM, Johansson L, Guo TH, Liu YS, Tong XH. Cryoprotectant-free ultra-rapid freezing of human spermatozoa in cryogenic vials. Andrologia. 2014;46:642–9.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  28. 28.

    Ali Mohamed MS. Slow cryopreservation is not superior to vitrification in human spermatozoa; an experimental controlled study. Iran J Reprod Med. 2015;13:633–44.

    PubMed  PubMed Central  Google Scholar 

  29. 29.

    Tongdee P, Sukprasert M, Satirapod C, Wongkularb A, Choktanasiri W. Comparison of cryopreserved human sperm between ultra rapid freezing and slow programmable freezing: effect on motility, morphology and DNA integrity. J Med Assoc Thailand. 2015;98:S33–42.

    Google Scholar 

  30. 30.

    Aizpurua J, Medrano L, Enciso M, Sarasa J, Romero A, Fernandez MA, Gomez-Torres MJ. New permeable cryoprotectant-free vitrification method for native human sperm. Hum Reprod. 2017;32:2007–15.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  31. 31.

    Karthikeyan M, Arakkal D, Mangalaraj AM, Kamath MS. Comparison of conventional slow freeze versus permeable cryoprotectant-free vitrification of abnormal semen sample: a randomized controlled trial. J Human Reprod Sci. 2019;12:150–5.

    Article  Google Scholar 

  32. 32.

    Le MT, Nguyen TTT, Nguyen TT, Nguyen VT, Nguyen TTA, Nguyen VQH, Cao NT. Cryopreservation of human spermatozoa by vitrification versus conventional rapid freezing: effects on motility, viability, morphology and cellular defects. Eur J Obstet Gynecol Reprod Biol. 2019;234:14–20.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  33. 33.

    Pabon D, Meseguer M, Sevillano G, Cobo A, Romero JL, Remohi J, de Los SMJ. A new system of sperm cryopreservation: evaluation of survival, motility, DNA oxidation, and mitochondrial activity. Andrology. 2019;7:293–301.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  34. 34.

    Spis E, Bushkovskaia A, Isachenko E, Todorov P, Sanchez R, Skopets V, Isachenko V. Conventional freezing vs. cryoprotectant-free vitrification of epididymal (MESA) and testicular (TESE) spermatozoa: three live births. Cryobiology. 2019;90:100–2.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  35. 35.

    Li YX, Zhou L, Lv MQ, Ge P, Liu YC, Zhou DX. Vitrification and conventional freezing methods in sperm cryopreservation: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2019;233:84–92.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  36. 36.

    Oldenhof H, Gojowsky M, Wang S, Henke S, Yu C, Rohn K, Wolkers WF, Sieme H. Osmotic stress and membrane phase changes during freezing of stallion sperm: mode of action of cryoprotective agents. Biol Reprod. 2013;88:68.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  37. 37.

    Schulz M, Risopatron J, Matus G, Pineda E, Rojas C, Isachenko V, Isachenko E, Sanchez R. Trehalose sustains a higher post-thaw sperm motility than sucrose in vitrified human sperm. Andrologia. 2017;49:1–3.

    Article  CAS  Google Scholar 

  38. 38.

    Merino O, Aguaguina WE, Esponda P, Risopatron J, Isachenko E, Isachenko V, Sanchez R. Protective effect of butylated hydroxytoluene on sperm function in human spermatozoa cryopreserved by vitrification technique. Andrologia. 2015;47:186–93.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  39. 39.

    Cohen J, Garrisi GJ, Congedo-Ferrara TA, Kieck KA, Schimmel TW, Scott RT. Cryopreservation of single human spermatozoa. Hum Reprod. 1997;12:994–1001.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  40. 40.

    Endo Y, Fujii Y, Shintani K, Seo M, Motoyama H, Funahashi H. Simple vitrification for small numbers of human spermatozoa. Reprod BioMed Online. 2012;24:301–7.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  41. 41.

    Herrler A, Eisner S, Bach V, Weissenborn U, Beier HM. Cryopreservation of spermatozoa in alginic acid capsules. Fertil Steril. 2006;85:208–13.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  42. 42.

    Stein A, Shufaro Y, Hadar S, Fisch B, Pinkas H. Successful use of the Cryolock device for cryopreservation of scarce human ejaculate and testicular spermatozoa. Andrology. 2015;3:220–4.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  43. 43.

    Hu E, Childress W, Tiersch TR. 3-D printing provides a novel approach for standardization and reproducibility of freezing devices. Cryobiology. 2017;76:34–40.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  44. 44.

    Cobo A, Domingo J, Perez S, Crespo J, Remohi J, Pellicer A. Vitrification: an effective new approach to oocyte banking and preserving fertility in cancer patients. Clin Transl Oncol. 2008;10:268–73.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  45. 45.

    Kuwayama M, Vajta G, Ieda S, Kato O. Comparison of open and closed methods for vitrification of human embryos and the elimination of potential contamination. Reprod BioMed Online. 2005;11:608–14.

    PubMed  Article  PubMed Central  Google Scholar 

  46. 46.

    Hosseini A, Khalili MA, Talebi AR, Agha-Rahimi A, Ghasemi-Esmailabad S, Woodward B, Yari N. Cryopreservation of low number of human spermatozoa; which is better: vapor phase or direct submerging in liquid nitrogen? Hum Fertil. 2019;22:126–32.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  47. 47.

    Liu F, Zou SS, Zhu Y, Sun C, Liu YF, Wang SS, Shi WB, Zhu JJ, Huang YH, Li Z. A novel micro-straw for cryopreservation of small number of human spermatozoon. Asian J Androl. 2017;19:326–9.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  48. 48.

    Berkovitz A, Miller N, Silberman M, Belenky M, Itsykson P. A novel solution for freezing small numbers of spermatozoa using a sperm vitrification device. Hum Reprod. 2018;33:1975–83.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  49. 49.

    Paffoni A, Palini S. There is another new method for cryopreserving small numbers of human sperm cells. Ann Transl Med. 2019;7(Suppl 1):1–4.

    Google Scholar 

  50. 50.

    Isachenko V, Rahimi G, Mallmann P, Sanchez R, Isachenko E. Technologies of cryoprotectant-free vitrification of human spermatozoa: asepticity as criterion of effectiveness. Andrology. 2017;5:1055–63.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  51. 51.

    Isachenko V, Isachenko E, Katkov II, Montag M, Dessole S, Nawroth F, Van Der Ven H. Cryoprotectant-free cryopreservation of human spermatozoa by vitrification and freezing in vapor: effect on motility, DNA integrity, and fertilization ability. Biol Reprod. 2004;71:1167–73.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  52. 52.

    Sanchez R, Fontecilla J, Isachenko E, Mora B, Isachenko V, Cabrillana ME. Temperatures in the devitrification process is essential for preserved morphological membrane integrity and sperm function in human spermatozoon. Fertil Steril. 2013;100:S183.

    Article  Google Scholar 

  53. 53.

    Mansilla MA, Merino O, Risopatron J, Isachenko V, Isachenko E, Sanchez R. High temperature is essential for preserved human sperm function during the devitrification process. Andrologia. 2016;48:111–3.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  54. 54.

    Bielanski A. A review of the risk of contamination of semen and embryos during cryopreservation and measures to limit cross-contamination during banking to prevent disease transmission in ET practices. Theriogenology. 2012;77:467–82.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  55. 55.

    Bielanski A. Biosafety in embryos and semen cryopreservation, storage, management and transport. Adv Exp Med Biol. 2014;753:429–65.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  56. 56.

    Bielanski A, Nadin-Davis S, Sapp T, Lutze-Wallace C. Viral contamination of embryos cryopreserved in liquid nitrogen. Cryobiology. 2000;40:110–6.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  57. 57.

    Morris GJ. The origin, ultrastructure, and microbiology of the sediment accumulating in liquid nitrogen storage vessels. Cryobiology. 2005;50:231–8.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  58. 58.

    Joaquim DC, Borges ED, Viana IGR, Navarro PA, Vireque AA. Risk of contamination of gametes and embryos during cryopreservation and measures to prevent cross-contamination. Biomed Res Int. 2017;2017:1840417.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  59. 59.

    Harrison AP Jr. Survival of bacteria upon repeated freezing and thawing. J Bacteriol. 1955;70:711–7115.

    PubMed  PubMed Central  Article  Google Scholar 

  60. 60.

    Piasecka-Serafin M. The effect of the sediment accumulated in containers under experimental conditions on the infection of semen stored directly in liquid nitrogen (−196 degree C). Bull Acad Pol Sci Biol. 1972;20:263–7.

    PubMed  CAS  PubMed Central  Google Scholar 

  61. 61.

    Schafer TW, Everett J, Silver GH, Came PE. Biohazard: virus-contaminated liquid nitrogen. Science. 1976;191:24–6.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  62. 62.

    Tedder RS, Zuckerman MA, Goldstone AH, Hawkins AE, Fielding A, Briggs EM, Irwin D, Blair S, Gorman AM, Patterson KG, et al. Hepatitis B transmission from contaminated cryopreservation tank. Lancet. 1995;346:137–40.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  63. 63.

    Cobo A, Bellver J, de los Santos MJ, Remohi J. Viral screening of spent culture media and liquid nitrogen samples of oocytes and embryos from hepatitis B, hepatitis C, and human immunodeficiency virus chronically infected women undergoing in vitro fertilization cycles. Fertil Steril. 2012;97:74–8.

    PubMed  Article  PubMed Central  Google Scholar 

  64. 64.

    Molina I, Mari M, Martinez JV, Novella-Maestre E, Pellicer N, Peman J. Bacterial and fungal contamination risks in human oocyte and embryo cryopreservation: open versus closed vitrification systems. Fertil Steril. 2016;106:127–32.

    PubMed  Article  PubMed Central  Google Scholar 

  65. 65.

    Mansuy JM, Dutertre M, Mengelle C, Fourcade C, Marchou B, Delobel P, Izopet J, Martin-Blondel G. Zika virus: high infectious viral load in semen, a new sexually transmitted pathogen? Lancet Infect Dis. 2016;16:405.

    PubMed  Article  PubMed Central  Google Scholar 

  66. 66.

    Nicastri E, Castilletti C, Liuzzi G, Iannetta M, Capobianchi MR, Ippolito G. Persistent detection of Zika virus RNA in semen for six months after symptom onset in a traveller returning from Haiti to Italy, February 2016. Euro Surveill. 2016;21:30314.

    PubMed Central  Article  Google Scholar 

  67. 67.

    Schiewe MC, Freeman M, Whitney JB, VerMilyea MD, Jones A, Aguirre M, Leisinger C, Adaniya G, Synder N, Chilton R, Behnke EJ. Comprehensive assessment of cryogenic storage risk and quality management concerns: best practice guidelines for ART labs. J Assist Reprod Genet. 2019;36:5–14.

    PubMed  PubMed Central  Article  Google Scholar 

  68. 68.

    McBurnie LD, Bardo B. Validation of sterile filtration of liquid nitrogen. Pharm Technol. 2002:74–82.

  69. 69.

    Arav A, Natan Y, Levi-Setti PE, Menduni F, Patrizio P. New methods for cooling and storing oocytes and embryos in a clean environment of −196 degrees C. Reprod BioMed Online. 2016;33:71–8.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  70. 70.

    Hu J, Zhao S, Xu C, Zhang L, Lu S, Cui L, Ma J, Chen ZJ. Liquid nitrogen vapor is comparable to liquid nitrogen for storage of cryopreserved human sperm: evidence from the characteristics of post-thaw human sperm. Fertil Steril. 2015;104(1253–1257):e1251–2.

    Google Scholar 

  71. 71.

    Diaz-Jimenez M, Dorado J, Pereira B, Ortiz I, Consuegra C, Bottrel M, Ortiz E, Hidalgo M. Vitrification in straws conserves motility features better than spheres in donkey sperm. Reprod Domest Anim. 2018;53(Suppl 2):56–8.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  72. 72.

    Kuleshova LL, Shaw JM. A strategy for rapid cooling of mouse embryos within a double straw to eliminate the risk of contamination during storage in liquid nitrogen. Hum Reprod. 2000;15:2604–9.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  73. 73.

    Perez O, Guerrero CA, Ferguson T, Douglas J, Rodriguez A, Hammitt D. Simplified closed double-straw system for oocyte, embryo and blastocyst vitrification. Fertil Steril. 2010;94:S105–6.

    Article  Google Scholar 

  74. 74.

    De Munck N, Santos-Ribeiro S, Stoop D, Van de Velde H, Verheyen G. Open versus closed oocyte vitrification in an oocyte donation programme: a prospective randomized sibling oocyte study. Hum Reprod. 2016;31:377–84.

    PubMed  Article  PubMed Central  Google Scholar 

  75. 75.

    Parmegiani L, Accorsi A, Bernardi S, Arnone A, Cognigni GE, Filicori M. A reliable procedure for decontamination before thawing of human specimens cryostored in liquid nitrogen: three washes with sterile liquid nitrogen (SLN2). Fertil Steril. 2012;98:870–5.

    PubMed  Article  CAS  PubMed Central  Google Scholar 

  76. 76.

    Vajta G, Rienzi L, Ubaldi FM. Open versus closed systems for vitrification of human oocytes and embryos. Reprod BioMed Online. 2015;30:325–33.

    PubMed  Article  PubMed Central  Google Scholar 

  77. 77.

    Chen Y, Zheng X, Yan J, Qiao J, Liu P. Neonatal outcomes after the transfer of vitrified blastocysts: closed versus open vitrification system. Reprod Biol Endocrinol. 2013;11:107.

    PubMed  PubMed Central  Article  Google Scholar 

  78. 78.

    Parmegiani L, Cognigni GE, Filicori M. Ultra-violet sterilization of liquid nitrogen prior to vitrification. Hum Reprod. 2009;24:2969.

    PubMed  Article  PubMed Central  Google Scholar 

  79. 79.

    Lahon A, Arya RP, Kneubehl AR, Vogt MB, Dailey Garnes NJ, Rico-Hesse R. Characterization of a Zika virus isolate from Colombia. PLoS Negl Trop Dis. 2016;10:e0005019.

    PubMed  PubMed Central  Article  Google Scholar 

  80. 80.

    Parmegiani L, Cognigni GE, Bernardi S, Cuomo S, Ciampaglia W, Infante FE, Tabarelli de Fatis C, Arnone A, Maccarini AChChang HJ,ang HJ,M, Filicori M. Efficiency of aseptic open vitrification and hermetical cryostorage of human oocytes. Reprod BioMed Online. 2011;23:505–12.

  81. 81.

    Rozati H, Handley T, Jayasena CN. Process and pitfalls of sperm cryopreservation. J Clin Med. 2017;6:1–13.

  82. 82.

    Heo YS, Nagrath S, Moore AL, Zeinali M, Irimia D, Stott SL, Toth TL, Toner M. “universal” vitrification of cells by ultra-fast cooling. Technology. 2015;3:64–71.

    PubMed  PubMed Central  Article  Google Scholar 

Download references

Acknowledgements

We are grateful to Mr. Christopher Lavergne’s and Miss Dandan Tao’s help with the language. We appreciate the literature support from Mr. Guolong Mo and Dr. Zhibin Ning.

Funding

This review did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Affiliations

Authors

Contributions

YT conceived and drafted the manuscript, ES, AS and MCL read and revised the manuscript. All authors approved the final version.

Corresponding author

Correspondence to Yong Tao.

Ethics declarations

Ethics approval and consent to participate

N/A

Consent for publication

The authors give our consent for information to be published in Reproductive Biology and Endocrinology. Yong Tao: ytao@conceive.ca; Erika Sanger: esanger@conceive.ca; Arpornrad Sae-wu: asaewu@conceive.ca; Marie-Claude Leveille: mleveille@conceive.ca.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tao, Y., Sanger, E., Saewu, A. et al. Human sperm vitrification: the state of the art. Reprod Biol Endocrinol 18, 17 (2020). https://doi.org/10.1186/s12958-020-00580-5

Download citation

Keywords

  • Cryopreservation
  • Vitrification
  • Contamination
  • Liquid nitrogen
  • Spermatozoa
  • Semen